Overview

Effect of Spironolactone and Vitamin E in Patients With Nonalcoholic Fatty Liver Disease

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The primary aim of the study is the effect of spironolactone and vitamin E versus vitamin E on serum levels of adipokines 52 weeks post-treatment.
Phase:
Phase 2
Details
Lead Sponsor:
Aristotle University Of Thessaloniki
Treatments:
alpha-Tocopherol
Spironolactone
Tocopherols
Tocotrienols
Vitamin E
Vitamins